SEMA3A and breast carcinoma: Sema3A has been shown to increase integrin expression and cell adhesion in breast carcinoma cells [20], while our results demonstrate that Sema3A increases integrin signaling, as indicated by increased pFAK397 at focal adhesions, on collagen and fibronectin (Figure 5).